Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH) after it became the first drug to hit two regulatory goals in a ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets. Financials include key reports ...

Titan Company Ltd. key Products/Revenue Segments include Jewellery, Other Operating Revenue, Watches, Eyewear, Others, Other Services for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, ...

There is currently no schedule data. The Schedule Release will be available on April.

We've verified that the organization Authenticator-Extension controls the domain: ...